News, Events & Resources
There’s a lot happening at Melinta. We are the company of the moment and enterprise of the future. Join us in realizing our vision — this is our story, and it’s going to be legendary.
Melinta Therapeutics Announces IDWeek 2024 Presentations Focused on Melinta’s Portfolio of Commercial and Investigational Stage Products
Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announced today, ten scientific presentations with data focused on Melinta’s portfolio of commercial and investigational stage products to be shared at Infectious Disease Week (IDWeek) 2024, Oct. 16-19, 2024, in Los Angeles, Californi
Melinta Therapeutics and Cidara Therapeutics Announce Licensing Agreement to Commercialize Rezafungin in the U.S.
July 27, 2022 Press Release Melinta Therapeutics and Cidara Therapeutics Announce Licensing Agreement to Commercialize Rezafungin in the U.S. MORRISTOWN, N.J., July 27, 2022 — Melinta Therapeutics,
Melinta Therapeutics Acquires U.S. Rights to TOPROL-XL® (metoprolol succinate) from New American Therapeutics
April 6, 2022 Press Release Melinta Therapeutics Acquires U.S. Rights to TOPROL-XL® (metoprolol succinate) from New American Therapeutics MORRISTOWN, N.J., Apr. 6, 2022 — Melinta Therapeutics, LLC
Melinta Therapeutics Announces Appointment of Peter Piliero as Vice President of Medical Affairs
March 14, 2022Press ReleaseMelinta Therapeutics Announces Appointment of Peter Piliero as Vice President of Medical Affairs MORRISTOWN, N.J., Mar. 14, 2022 — Melinta Therapeutics, LLC...